BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 23237666)

  • 1. Whole-genome reconstruction and mutational signatures in gastric cancer.
    Nagarajan N; Bertrand D; Hillmer AM; Zang ZJ; Yao F; Jacques PÉ; Teo AS; Cutcutache I; Zhang Z; Lee WH; Sia YY; Gao S; Ariyaratne PN; Ho A; Woo XY; Veeravali L; Ong CK; Deng N; Desai KV; Khor CC; Hibberd ML; Shahab A; Rao J; Wu M; Teh M; Zhu F; Chin SY; Pang B; So JB; Bourque G; Soong R; Sung WK; Tean Teh B; Rozen S; Ruan X; Yeoh KG; Tan PB; Ruan Y
    Genome Biol; 2012 Dec; 13(12):R115. PubMed ID: 23237666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The chronological sequence of somatic mutations in early gastric carcinogenesis inferred from multiregion sequencing of gastric adenomas.
    Lim CH; Cho YK; Kim SW; Choi MG; Rhee JK; Chung YJ; Lee SH; Kim TM
    Oncotarget; 2016 Jun; 7(26):39758-39767. PubMed ID: 27175599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exome sequencing of gastric adenocarcinoma identifies recurrent somatic mutations in cell adhesion and chromatin remodeling genes.
    Zang ZJ; Cutcutache I; Poon SL; Zhang SL; McPherson JR; Tao J; Rajasegaran V; Heng HL; Deng N; Gan A; Lim KH; Ong CK; Huang D; Chin SY; Tan IB; Ng CC; Yu W; Wu Y; Lee M; Wu J; Poh D; Wan WK; Rha SY; So J; Salto-Tellez M; Yeoh KG; Wong WK; Zhu YJ; Futreal PA; Pang B; Ruan Y; Hillmer AM; Bertrand D; Nagarajan N; Rozen S; Teh BT; Tan P
    Nat Genet; 2012 May; 44(5):570-4. PubMed ID: 22484628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing.
    Le Gallo M; Rudd ML; Urick ME; Hansen NF; Zhang S; ; Lozy F; Sgroi DC; Vidal Bel A; Matias-Guiu X; Broaddus RR; Lu KH; Levine DA; Mutch DG; Goodfellow PJ; Salvesen HB; Mullikin JC; Bell DW
    Cancer; 2017 Sep; 123(17):3261-3268. PubMed ID: 28485815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational landscape of gastric cancer and clinical application of genomic profiling based on target next-generation sequencing.
    Cai H; Jing C; Chang X; Ding D; Han T; Yang J; Lu Z; Hu X; Liu Z; Wang J; Shang L; Wu S; Meng P; Lin L; Zhao J; Nie M; Yin K
    J Transl Med; 2019 Jun; 17(1):189. PubMed ID: 31164161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic mutation profiles of MSI and MSS colorectal cancer identified by whole exome next generation sequencing and bioinformatics analysis.
    Timmermann B; Kerick M; Roehr C; Fischer A; Isau M; Boerno ST; Wunderlich A; Barmeyer C; Seemann P; Koenig J; Lappe M; Kuss AW; Garshasbi M; Bertram L; Trappe K; Werber M; Herrmann BG; Zatloukal K; Lehrach H; Schweiger MR
    PLoS One; 2010 Dec; 5(12):e15661. PubMed ID: 21203531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deep Targeted Sequencing and Its Potential Implication for Cancer Therapy in Chinese Patients with Gastric Adenocarcinoma.
    Yu P; Wang Y; Yu Y; Wang A; Huang L; Zhang Y; Liu W; Wu H; Yao M; Du YA; Cheng X
    Oncologist; 2021 May; 26(5):e756-e768. PubMed ID: 33511732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The mutational burdens and evolutionary ages of early gastric cancers are comparable to those of advanced gastric cancers.
    Kim TM; Jung SH; Kim MS; Baek IP; Park SW; Lee SH; Lee HH; Kim SS; Chung YJ; Lee SH
    J Pathol; 2014 Nov; 234(3):365-74. PubMed ID: 25042771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of somatic mutations in TP53 in gastric epithelium with Helicobacter pylori infection.
    Shimizu T; Marusawa H; Matsumoto Y; Inuzuka T; Ikeda A; Fujii Y; Minamiguchi S; Miyamoto S; Kou T; Sakai Y; Crabtree JE; Chiba T
    Gastroenterology; 2014 Aug; 147(2):407-17.e3. PubMed ID: 24786892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 immunostaining cannot be used to predict TP53 mutations in gastric cancer: results from a large Central European cohort.
    Schoop I; Maleki SS; Behrens HM; Krüger S; Haag J; Röcken C
    Hum Pathol; 2020 Nov; 105():53-66. PubMed ID: 32971129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastric poorly cohesive carcinoma: a correlative study of mutational signatures and prognostic significance based on histopathological subtypes.
    Kwon CH; Kim YK; Lee S; Kim A; Park HJ; Choi Y; Won YJ; Park DY; Lauwers GY
    Histopathology; 2018 Mar; 72(4):556-568. PubMed ID: 28873240
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist.
    Tsuruta S; Ohishi Y; Fujiwara M; Ihara E; Ogawa Y; Oki E; Nakamura M; Oda Y
    Hum Pathol; 2019 Jun; 88():27-38. PubMed ID: 30946937
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic mutation analysis of human gastric adenocarcinomas using ion torrent sequencing platform.
    Xu Z; Huo X; Ye H; Tang C; Nandakumar V; Lou F; Zhang D; Dong H; Sun H; Jiang S; Zhang G; Liu Z; Dong Z; Guo B; He Y; Yan C; Wang L; Su Z; Li Y; Gu D; Zhang X; Wu X; Wei X; Hong L; Zhang Y; Yang J; Gong Y; Tang C; Jones L; Huang XF; Chen SY; Chen J
    PLoS One; 2014; 9(7):e100442. PubMed ID: 25025766
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of 7,815 cancer exomes reveals associations between mutational processes and somatic driver mutations.
    Poulos RC; Wong YT; Ryan R; Pang H; Wong JWH
    PLoS Genet; 2018 Nov; 14(11):e1007779. PubMed ID: 30412573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Intron Microsatellite Instability and Exon Mutational Profile of
    Huo X; Xiao X; Zhang S; Zhou D; Chen Z
    Anticancer Res; 2017 Aug; 37(8):4507-4514. PubMed ID: 28739746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutational burden and signatures in 4000 Japanese cancers provide insights into tumorigenesis and response to therapy.
    Hatakeyama K; Nagashima T; Ohshima K; Ohnami S; Ohnami S; Shimoda Y; Serizawa M; Maruyama K; Naruoka A; Akiyama Y; Urakami K; Kusuhara M; Mochizuki T; Yamaguchi K
    Cancer Sci; 2019 Aug; 110(8):2620-2628. PubMed ID: 31152682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic and epigenomic heterogeneity in molecular subtypes of gastric cancer.
    Lim B; Kim JH; Kim M; Kim SY
    World J Gastroenterol; 2016 Jan; 22(3):1190-201. PubMed ID: 26811657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated review of gastric cancer in the next-generation sequencing era: insights from bench to bedside and vice versa.
    Yamamoto H; Watanabe Y; Maehata T; Morita R; Yoshida Y; Oikawa R; Ishigooka S; Ozawa S; Matsuo Y; Hosoya K; Yamashita M; Taniguchi H; Nosho K; Suzuki H; Yasuda H; Shinomura Y; Itoh F
    World J Gastroenterol; 2014 Apr; 20(14):3927-37. PubMed ID: 24744582
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next-generation Sequencing in the Management of Gastric and Esophageal Cancers.
    Rubinstein JC; Nicolson NG; Ahuja N
    Surg Clin North Am; 2019 Jun; 99(3):511-527. PubMed ID: 31047039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal Structures of Regionally Synchronous Gastric Adenomas and Carcinomas.
    Jung SH; Kim SY; An CH; Lee SH; Jung ES; Park HC; Kim MS; Chung YJ; Lee SH
    Clin Cancer Res; 2018 Oct; 24(19):4715-4725. PubMed ID: 29945994
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.